U.S. markets closed

Arrowhead Pharmaceuticals, Inc. (ARWR)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
79.66-2.54 (-3.09%)
At close: 4:00PM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Price Crosses Moving Average

Price Crosses Moving Average

Previous Close82.20
Open83.01
Bid79.66 x 800
Ask80.45 x 1200
Day's Range79.00 - 84.34
52 Week Range19.51 - 92.60
Volume1,061,886
Avg. Volume891,696
Market Cap8.268B
Beta (5Y Monthly)1.40
PE Ratio (TTM)N/A
EPS (TTM)-1.00
Earnings DateMay 05, 2021 - May 10, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est92.42
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • Is Arrowhead Pharmaceuticals (ARWR) Stock a Buy For 2021?
    Insider Monkey

    Is Arrowhead Pharmaceuticals (ARWR) Stock a Buy For 2021?

    Baron Health Care Fund recently published its fourth-quarter commentary – a copy of which can be downloaded here. During the fourth quarter of 2020, the Baron Health Care Fund returned 17.1% (institutional shares). In comparison, the benchmark S&P 500 Index was up 12.15%, while the Russell 3000 Health Care Index was up 10.08%. You should […]

  • Is Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) Popular Amongst Institutions?
    Simply Wall St.

    Is Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) Popular Amongst Institutions?

    A look at the shareholders of Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) can tell us which group is most powerful. Generally speaking, as a company grows, institutions will increase their ownership. Conversely, insiders often decrease their ownership over time. Companies that used to be publicly owned tend to have lower insider ownership.

  • ARWR: Multiple Data Readouts in 2021…
    Zacks Small Cap Research

    ARWR: Multiple Data Readouts in 2021…

    By David Bautz, PhD NASDAQ:ARWR READ THE FULL ARWR RESEARCH REPORT Business Update Multiple Catalysts in 2021 Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR) is developing medicines that cause gene silencing using RNA interference (RNAi), a specific means of inhibiting the expression of genes and stopping the production of a specific protein. The company has a deep and diverse pipeline consisting of